Chai Discovery has completed a $130 million Series B financing that the artificial intelligence (AI)-based antibody designer says will help it accelerate its research and product development, as well ...

The results of the study could improve immunotherapy treatment for patients with colorectal and other barrier-tissue cancers.

SMRTS, a smart mRNA system, enables cell‑selective gene expression, expanding the mRNA toolbox for precision cancer therapies.

Now, the Lundquist Institute (TLI) and Vitalex Biosciences announce that they will move forward in the development of the second-generation fungal vaccine candidate known as VXV‑01—up to and including ...